US biotech IGM Biosciences (Nasdaq: IGMS), which is developing and delivering medicines to treat patients with autoimmune and ...

Cambridge, Massachusetts-based Vor Bio has confirmed that it will halt clinical and manufacturing operations, including its ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 4 undervalued stocks in the Pharmaceuticals industry for Friday, May 09, 2025. Let’s take a ...

After losing its powerhouse partner, IGM Biosciences closed “most” of its labs and offices and initiated a strategic review ...

Sanofi has scrapped its collaboration with IGM Biosciences, eliminating the biotech’s l | Sanofi has scrapped its ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued stocks in the Pharmaceuticals industry for Tuesday, May 06, 2025. Let’s take ...

On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...

Sanofi India: Sanofi India had declared a final dividend of Rs 117 per equity share for the financial year ended December 31, 2024. The Board had recommended the payout in its meeting on February 27, ...

Muthoot Finance-The Board Meeting held on April 21, 2025, had Considered and approved the payment of an interim dividend of Rs. 26 (Rupees Twenty Six) per equity share (260%) for the Financial ...

Sanofi signed a deal with Earendil Labs for $125 million upfront and $1.72 billion in milestone payments. Regeneron Pharmaceuticals signed a deal worth more than $3 billion with contract drug ...

Hello everyone. This is Thomas Kudsk Larsen from the Sanofi IR team. Welcome to the Q1 2025 Conference Call for Investors and Analysts. As usual you can find the slides on sanofi.com. Please turn ...

The board of directors of Sanofi (NASDAQ:SNY) have proposed an annual dividend of €3.92 per share, an increase of 4.26% from prior dividend of €3.76 per share. Sanofi intends to execute a ...